Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19
by Zach Henderson, Chief Commercial Officer, Glooko
Zach Henderson, Chief Commercial Officer, Glooko
As with so many aspects of our daily lives, the impact of the COVID-19 pandemic on clinical trials was both widespread and monumental. Thousands of trials an estimated 80% of non-COVID-19 trials came to a halt or were interrupted by the pandemic, which challenged the ability to conduct trials safely and effectively and was complicated by the reality that trials often deal with the populations most at risk from COVID-19 exposure
1.
In response, clinical researchers turned to a range of solutions to address the effects of the pandemic on trials. And while, in most cases, it’s premature to definitively determine which solutions will outlast the pandemic, probably the most widely used and enduring will be the decentralized model for conducting clinical trials, including the digital health
Medable Secures Another $78 Million Funding to Fuel Digital Innovation for Patient-Centered Drug Development biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Tyler Jacks, Ph.D., after 19 years. The director role will be taken over by
Matthew Vander Heiden, M.D., Ph.D., a professor of biology at MIT and a medical oncologist at Dana-Farber Cancer Institute. He became a member of the Koch Institute in 2010 and took over for Jacks on Thursday, MIT said. Jacks will continue to lead the Bridge Project, which unites bioegnineers, cancer scientists and clinical oncologists from the Koch Institute and the Dana-Farber/Harvard Cancer Center.
> Atara Biotherapeutics ushered
Amie Krause into the role of senior vice president and chief people officer April 2. Since joining the company, Krause has been the driving force behind Atara’s human people department, advocating for employees across the organization. She doubles as a founding leader of Atara’s Women’s Alliance and is part of the Healthcare Businesswomen’s Association. Before signing on with Atara, Krause held several top human resources roles at Amgen, including HR lead for the
Medable Hires Dr Pamela Tenaerts as Chief Scientific Officer to Lead Research and Share Best Practices for Decentralized Trials apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Scientific American
COVID Showed How Trials for New Drugs Could Be Faster and Better
The pandemic has spotlighted ways to make clinical trials easier on patients and better for science, a heart drug researcher says
Advertisement
A dozen years and a billion or more dollars that is what it typically takes to bring a new drug from the lab to your medicine cabinet. Testing medications on patients has become a slow, arduous process. People, even those who are desperate to participate, often have to travel long distances to a study site and make the trip over and over again. For scientists, coordinating the paperwork among a large number of research centers can be extremely laborious and time-consuming.